» Articles » PMID: 32708527

The Impact of Protein Supplementation Targeted at Improving Muscle Mass on Strength in Cancer Patients: A Scoping Review

Overview
Journal Nutrients
Date 2020 Jul 26
PMID 32708527
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Deterioration of muscle strength during cancer results in functional limitation, poor quality of life and reduced survival. The indirect effects on muscle strength of nutritional interventions based on protein and amino acid derivatives targeted at improving muscle mass are poorly documented. A scoping review was performed to examine the available evidence on the effects of proteins, amino acids and their derivatives on muscle strength in adult cancer patients. Pubmed and Scopus databases were searched to identify research articles published in the last 10 years. Fourteen studies met the inclusion criteria, showing that changes in muscle strength following protein or amino acid supplementation are generally concordant with those in muscle mass in cancer patients. Administration of both energy and proteins in the presence of reduced oral intakes results in more robust effects on both muscle strength and mass. It is not clear whether this is due to the correction of the energy deficit or to an interaction between proteins and other macronutrients. The optimal mixture, type, and dose of amino acid/protein supplementation alone or in combination with other anabolic strategies should be determined to provide the best nutritional approach in cancer.

Citing Articles

Muscle loss in cancer cachexia: what is the basis for nutritional support?.

Faiad J, Andrade M, de Castro G, de Resende J, Coelho M, Aquino G Front Pharmacol. 2025; 16:1519278.

PMID: 40078277 PMC: 11897308. DOI: 10.3389/fphar.2025.1519278.


The combined effect of physical exercise, pranayama, and diet on fatigue in adult cancer patients undergoing chemotherapy: a randomized controlled trial.

Mehta S, Joshi A, Ramteke M, Tandiya P Support Care Cancer. 2024; 32(9):618.

PMID: 39207544 DOI: 10.1007/s00520-024-08821-8.


Effects of protein-enriched nutritional support on skeletal muscle mass and rehabilitative outcomes in brain tumor patients: a randomized controlled trial.

Cho K, Han E, Jung M, Kang C, Shin J, Im S Sci Rep. 2024; 14(1):12909.

PMID: 38839858 PMC: 11153212. DOI: 10.1038/s41598-024-63551-5.


Protein intake in cancer: Does it improve nutritional status and/or modify tumour response to chemotherapy?.

Boutiere M, Cottet-Rousselle C, Coppard C, Couturier K, Feart C, Couchet M J Cachexia Sarcopenia Muscle. 2023; 14(5):2003-2015.

PMID: 37667552 PMC: 10570073. DOI: 10.1002/jcsm.13276.


Amino Acids in Cancer and Cachexia: An Integrated View.

Ragni M, Fornelli C, Nisoli E, Penna F Cancers (Basel). 2022; 14(22).

PMID: 36428783 PMC: 9688864. DOI: 10.3390/cancers14225691.


References
1.
Mir O, Coriat R, Blanchet B, Durand J, Boudou-Rouquette P, Michels J . Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One. 2012; 7(5):e37563. PMC: 3364283. DOI: 10.1371/journal.pone.0037563. View

2.
Deluche E, Leobon S, Desport J, Venat-Bouvet L, Usseglio J, Tubiana-Mathieu N . Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2017; 26(3):861-868. PMC: 5785600. DOI: 10.1007/s00520-017-3902-6. View

3.
Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

4.
Baracos V, Arribas L . Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018; 29(suppl_2):ii1-ii9. DOI: 10.1093/annonc/mdx810. View

5.
Morishita S, Tsubaki A, Fu J, Mitobe Y, Onishi H, Tsuji T . Cancer survivors exhibit a different relationship between muscle strength and health-related quality of life/fatigue compared to healthy subjects. Eur J Cancer Care (Engl). 2018; 27(4):e12856. DOI: 10.1111/ecc.12856. View